Klingman & Associates’s Sanofi SNY Stock Holding History

Klingman & Associates’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-464	Closed	-$22K	–	425
2015 Q3	$22K	Hold	464	–	–	0.01%	255
2015 Q2	$23K	Buy	+464	New	+$23.5K	0.01%	244

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Klingman & Associates's SNY Position: Q4 2015 in Review

Klingman & Associates sold out of Sanofi (SNY) in Q4 2015, closing a stake of 464 shares — an estimated $22K sold.

Klingman & Associates first reported a position in SNY in Q2 2015 and held it in 2 quarters. The position peaked at $23K in Q2 2015. 477 funds tracked by Wall St. Rank hold SNY as of Q4 2015.

Klingman & Associates reported no remaining Sanofi position as of Q4 2015 after selling out during the quarter.
Klingman & Associates sold 464 Sanofi shares in Q4 2015, an estimated $22K.
Klingman & Associates first reported a position in Sanofi in Q2 2015 and held it in 2 quarters.
Klingman & Associates's Sanofi position peaked at $23K in Q2 2015.
477 funds tracked by Wall St. Rank held Sanofi as of Q4 2015.

Based on Klingman & Associates's 13F filing for Q4 2015, filed 9 Feb 2016.